000			01938 a2200469 4500
005			20250514160132.0
264		0	_c20031104
008			200311s 0 0 eng d
022			_a1529-2401
040			_aNLM _beng _cNLM
100	1		_aIravani, Mahmoud M
245	0	0	_a3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates. _h[electronic resource]
260			_bThe Journal of neuroscience : the official journal of the Society for Neuroscience _cOct 2003
300			_a9107-15 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
650	0	4	_aAnimals
650	0	4	_aAntiparkinson Agents _xadverse effects
650	0	4	_aBehavior, Animal _xdrug effects
650	0	4	_aCallithrix
650	0	4	_aDisease Models, Animal
650	0	4	_aDopamine Agonists _xpharmacology
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDyskinesia, Drug-Induced _xetiology
650	0	4	_aFemale
650	0	4	_aLevodopa _xadverse effects
650	0	4	_aMale
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aN-Methyl-3,4-methylenedioxyamphetamine _xtherapeutic use
650	0	4	_aParkinsonian Disorders _xchemically induced
650	0	4	_aReceptor, Serotonin, 5-HT1B
650	0	4	_aReceptors, Serotonin _xdrug effects
650	0	4	_aReceptors, Serotonin, 5-HT1
650	0	4	_aSerotonin Antagonists _xpharmacology
650	0	4	_aSerotonin Receptor Agonists _xpharmacology
650	0	4	_aSelective Serotonin Reuptake Inhibitors _xpharmacology
700	1		_aJackson, Michael J
700	1		_aKuoppamäki, Mikko
700	1		_aSmith, Lance A
700	1		_aJenner, Peter
773	0		_tThe Journal of neuroscience : the official journal of the Society for Neuroscience _gvol. 23 _gno. 27 _gp. 9107-15
999			_c14293458 _d14293458